arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2603.19368physics.med-ph
收藏

超越肿瘤:用于前列腺癌阴性PSMA PET/CT扫描的复发倾向放射组学在预后评估中的应用

Beyond the Tumor: Recurrence-Prone Radiomics for Prognostication in Negative PSMA PET/CT scans of Prostate Cancer

BC Cancer Research(BC癌症研究中心);Molecular Imaging and Therapy, BC Cancer(BC癌症分子成像与治疗部);Institut de Biologie Valrose, Université Côte d'Azur, CNRS, Inserm(蔚蓝海岸大学瓦罗斯生物学研究所(CNRS,Inserm));University of British Columbia(不列颠哥伦比亚大学);Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine(约翰斯·霍普金斯医学院拉塞尔·H·摩根放射学与放射科学系);Medical Physics Department, School of Medicine, Iran University of Medical Sciences(伊朗医科大学医学院医学物理系);Department of Nuclear Medicine, IKHC, Tehran University of Medical Science(德黑兰医科大学核医学科(IKHC));Research Center for Nuclear Medicine, Tehran University of Medical Sciences(德黑兰医科大学核医学研究中心)
Fereshteh Yousefirizi, Sara Harsini, Mobin Mohebi, Ian Alberts, Tahir Yusufaly, Monica Luo, Hamid Abdollahi, Elmira Yazdani, Soheila Mirabedin, Maziar Sabouri, … 展开作者

Fereshteh Yousefirizi, Sara Harsini, Mobin Mohebi, Ian Alberts, Tahir Yusufaly, Monica Luo, Hamid Abdollahi, Elmira Yazdani, Soheila Mirabedin, Maziar Sabouri, Parham Geramifar, Peyman Sheikhzadeh, Patrick Martineau, Don Wilson, Francois Benard, Carlos Uribe, Arman Rahmim

AI总结:

研究利用放射组学特征预测前列腺癌生物复发患者阴性PSMA PET/CT扫描的临床进展,结合PET/CT放射组学与临床变量显著提升了预后评估性能。

摘要:

在前列腺癌生物复发且PSMA PET/CT阴性患者中,从易复发器官提取的放射组学特征可预测临床进展和无进展生存。在132例患者队列中,结合PET/CT放射组学与临床变量显著提高了预后性能(C指数0.74 vs. 0.65)。模型性能受读者诊断确定性影响,但在外部验证中仍保持稳健。这些发现表明,来自视觉阴性扫描的放射组学可捕捉亚临床疾病,并为风险分层提供额外价值。

英文摘要:

In patients with biochemical recurrence of prostate cancer and negative PSMA PET/CT, radiomics features extracted from recurrence-prone organs can predict clinical progression and progression-free survival. In a cohort of 132 patients, combining PET/CT radiomics with clinical variables significantly improved prognostic performance (C-index 0.74 vs. 0.65). Model performance was influenced by reader diagnostic certainty and remained robust on external validation. These findings suggest that radiomics from visually negative scans capture subclinical disease and provide added value for risk stratification.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑